{
    "2020-05-14": [
        [
            {
                "time": "2020-05-14",
                "original_text": "午间公告2020年5月14日星期四",
                "features": {
                    "keywords": [
                        "华大基因",
                        "全资子公司",
                        "医疗器械注册证变更"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "百度AI发布颠覆性疫苗基因优化设计算法 加速新冠疫苗研发（股）",
                "features": {
                    "keywords": [
                        "百度AI",
                        "疫苗",
                        "基因优化设计算法",
                        "新冠疫苗研发"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "存货应收双增，疫情下的华大基因，到底是昙花一现还是王者归来？",
                "features": {
                    "keywords": [
                        "华大基因",
                        "存货应收双增",
                        "疫情"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-14",
                "original_text": "投资者提问：请问，华大基因持有华大因源的63.53%的股份，像新冠肺炎病毒",
                "features": {
                    "keywords": [
                        "华大基因",
                        "华大因源",
                        "股份持有",
                        "新冠肺炎病毒"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}